TOKYO -- The announcement that Takeda Pharmaceutical is mulling a bid for Irish drugmaker Shire has sent the Japanese company's shares diving.
Investors fear such a large acquisition would put the Japanese company under a heavy debt load and erode its otherwise healthy finances.
